首页 › 基金 › ARMISTICE CAPITAL, LLC › PTCT
ARMISTICE CAPITAL, LLC 对 PTCT 的持仓历史
PTC THERAPEUTICS INC · 医疗保健
ARMISTICE CAPITAL, LLC 在 Q3 2026 的 13F 申报中披露持有 PTCT(PTC THERAPEUTICS INC)1,297,510 股,市值约 US$84.1M,约占其申报组合的 1.15%,在其申报持仓中市值排名第 5 位。 ARMISTICE CAPITAL, LLC 最近 13 个申报季度中有 13 个季度披露了 PTCT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
ARMISTICE CAPITAL, LLC 对 PTCT 的持仓演变
ARMISTICE CAPITAL, LLC 于 Q3 2023 首次披露 PTCT 持仓:6,150,000 股(约 US$137.8M)。 该持仓在 Q4 2024 达到峰值 6,378,000 股,市值约 US$287.9M。 在 13 次申报中,ARMISTICE CAPITAL, LLC 5 次增持、7 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,297,510 股、市值约 US$84.1M,环比增持 637,510 股。。 持仓曾出现大幅变动:Q1 2026 减持约 86% (随后一个季度股价上涨 20%)、Q2 2026 增持约 69% (随后一个季度股价下跌 21%)、Q3 2026 增持约 97% (随后一个季度股价下跌 2%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 6.15M | $137.82M | 新进 |
| Q4 2023 | 6.86M | $189.17M | 增持 |
| Q1 2024 | 6.76M | $196.76M | 减持 |
| Q2 2024 | 6.96M | $212.90M | 增持 |
| Q3 2024 | 7.23M | $268.41M | 增持 |
| Q4 2024 | 6.38M | $287.90M | 减持 |
| Q1 2025 | 5.43M | $276.96M | 减持 |
| Q2 2025 | 4.74M | $231.28M | 减持 |
| Q3 2025 | 3.28M | $201.13M | 减持 |
| Q4 2025 | 2.80M | $212.83M | 减持 |
| Q1 2026 | 390.00K | $26.57M | 减持 |
| Q2 2026 | 660.00K | $53.84M | 增持 |
| Q3 2026 | 1.30M | $84.05M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PTCT 与 13F 数据
PTCT(PTC THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 PTCT,申报仓位最大的包括:TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$174.9M), TANG CAPITAL MANAGEMENT LLC (US$122.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PTCT 的基金
- TORONTO DOMINION BANK 2.17M 股 · $176.67M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.70M 股 · $174.86M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M 股 · $122.36M · Q2 2026
- Hood River Capital Management LLC 1.76M 股 · $113.77M · Q3 2026
- RTW INVESTMENTS, LP 1.62M 股 · $104.67M · Q3 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.24M 股 · $80.11M · Q3 2026
- Palo Alto Investors LP 918.85K 股 · $74.95M · Q2 2026
- Parkman Healthcare Partners LLC 700.39K 股 · $45.37M · Q3 2026
更多关于 ARMISTICE CAPITAL, LLC
常见问题
How long has ARMISTICE CAPITAL, LLC held PTCT?
ARMISTICE CAPITAL, LLC has disclosed PTCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ARMISTICE CAPITAL, LLC's current position in PTCT?
As of Q3 2026, ARMISTICE CAPITAL, LLC holds 1.30M shares of PTCT (PTC THERAPEUTICS INC), valued at $84.05M, representing 1.15% of its reported portfolio and ranking #5.
Has ARMISTICE CAPITAL, LLC been buying or selling PTCT?
In the latest 13F filing (Q3 2026), ARMISTICE CAPITAL, LLC increased its position in PTCT. The position peaked in Q4 2024 at 6.38M shares.
Which other funds hold PTCT?
Other major institutional holders of PTCT include TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, TANG CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.